Chimeric PRR T-cell-engager targeting cell surface β-1,3-glucan for invasive candidiasis.
Invasive candidiasis, primarily caused by Candida albicans, represents the most common fungal disease among hospitalized patients and poses a significant threat to human health.
Yu Fang Sun +8 more
doaj +1 more source
Mycograb for the Treatment of Invasive Candidiasis [PDF]
Raoul, Herbrecht +2 more
openaire +2 more sources
Clinical characteristics and outcomes of invasive fungal infections in critically ill patients with liver cirrhosis. [PDF]
Seeßle J +5 more
europepmc +1 more source
The Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis. [PDF]
Zubovskaia A, Vazquez JA.
europepmc +1 more source
In Vivo Evaluation of a Nanoemulsion-Delivered Chromium(III)-Triazole Complex Against Fluconazole-Resistant <i>Candida albicans</i>. [PDF]
Bedoya-Florez MV +7 more
europepmc +1 more source
Hepatic Candidiasis Following Drug-Induced Neutropenia in ANCA-Associated Vasculitis: A Diagnostic Challenge. [PDF]
Park JH +7 more
europepmc +1 more source
Invasive gastric candidiasis presenting as gastric perforation in an immunocompetent adult: a rare case report. [PDF]
Memon AS, Shah M, Fiza B, Shaikh AG.
europepmc +1 more source
Dynamics of 1,3-β-D-Glucan in Invasive Candidiasis: A Narrative Review of Microbiological Aspects and Diagnostic Implications. [PDF]
Calvo M +3 more
europepmc +1 more source
Disseminated Papulopustular Candidiasis in an Immunocompetent adult: A case report. [PDF]
Neetha TR +9 more
europepmc +1 more source
IFUCISTRATEGY: A Spanish Survey on the Management of Invasive Fungal Infection (IFI) in Critically Ill Patients. [PDF]
Zaragoza R +4 more
europepmc +1 more source

